• 7028 malaria professionals are enjoying the free benefits of MalariaWorld today

Treatment

Open Access | Costs analysis of the treatment of imported malaria

Author(s): 
Svihrova V, Szilagyiova M, Novakova E, Svihra J, Hudeckova H
Reference: 
Malaria Journal 2012, 11:1 (2 January 2012)
Contact email: 
svihrova@jfmed.uniba.sk

MalariaWorldThe analysis confirmed statistically-significant differences between the direct and indirect costs of treatment with and without chemoprophylaxis for patients with imported malaria.

Open Access | Cost-effectiveness of malaria microscopy and rapid diagnostic tests versus presumptive diagnosis: implications for malaria control in Uganda

Author(s): 
Batwala V, Magnussen P, Hansen KS, Nuwaha F
Reference: 
Malaria Journal 2011, 10:372 (19 December 2011)
Contact email: 
vkbatwala@gmail.com

MalariaWorldRDT was cost effective in both low and high transmission settings.

Plasmodium vivax treatments: what are we looking for?

Author(s): 
Price, Ric N.; Douglas, Nicholas M.; Anstey, Nicholas M.; von Seidlein, Lorenz
Reference: 
C urrent Opinion in Infectious Diseases, December 2011 - Volume 24 - Issue 6 - p 578–585

MalariaWorldIn regions coendemic for P. vivax and P. falciparum, a unified treatment policy for malaria of any parasitological cause is likely to confer the greatest individual and public health benefit.

Open Access | A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon

Author(s): 
Frank M, Lehners N, Mayengue PI, Gabor J, Dal-Bianco M, Kombila DU, Mombo Ngoma G, Supan C, Lell B, Ntoumi F, Grobusch MP, Dietz K, Kremsner PG
Reference: 
Malaria Journal 2011, 10:304 (17 October 2011)

MalariaWorldFour years after the withdrawal of CQ from national treatment guidelines the prevalence of the mutant pfcrt allele remains at 97%.

Three unusual presentations of plasmodium vivax malaria

Author(s): 
Satyendra Kumar Sonkar, Ravi Uniyal, and Gyanendra Kumar Sonkar
Reference: 
Trop Doct October 2011 vol. 41 no. 4 240-241
Contact email: 
satyendra.sonkar@gmail.com

We present three cases of unusual and complicated malaria caused by Plasmodium vivax.

Can lay community health workers be trained to use diagnostics to distinguish and treat malaria and pneumonia in children? Lessons from rural Uganda

Author(s): 
D. Mukanga, R. Babirye, S. Peterson, G. W. Pariyo, G. Ojiambo, J. K. Tibenderana, P. Nsubuga and K. Kallander
Reference: 
Tropical Medicine & International Health, Volume 16, Issue 10, pages 1234–1242, October 2011
Contact email: 
dmukanga@musph.ac.ug

Community health workers can be trained to use RDTs and timers to assess and manage malaria and pneumonia in children.

Do poor people use poor quality providers? Evidence from the treatment of presumptive malaria in Nigeria (pages 1087–1098)

Author(s): 
Obinna Onwujekwe, Kara Hanson and Benjamin Uzochukwu
Reference: 
Tropical Medicine & International Health, Volume 16, Issue 9, pages 1087–1098, September 2011
Contact email: 
Obinna.Onwujekwe@unn.edu.ng

Everybody used poor quality malaria treatment services but the poor people used providers with poor quality malaria treatment services more than others.

Open Access | Accuracy of malaria rapid diagnostic tests in community studies and their impact on treatment of malaria in an area with declining malaria burden in north-eastern Tanzania

Author(s): 
Ishengoma DS, Francis F, Mmbando BP, Lusingu JP, Magistrado P, Alifrangis M, Theander TG, Bygbjerg IC, Lemnge MM
Reference: 
Malaria Journal 2011, 10:176 (26 June 2011)
Contact email: 
dishengoma@tanga.mimcom.net

Although RDTs had low sensitivity and specificity, which varied widely depending on fever and parasite density, using RDTs reduced over-treatment with anti-malarials significantly.

Plasmodium berghei proteome changes in response to SSJ-183 treatment

Author(s): 
Jun Lu, Chika Arai, Abu Bakar Md, Masataka Ihara
Reference: 
Bioorganic & Medicinal Chemistry, Volume 19, Issue 13, 1 July 2011, Pages 4144-4147
Contact email: 
m-ihara@hoshi.ac.jp

The benzo[a]phenoxazine derivative, SSJ-183 has shown excellent anti-malarial efficacy and safety.

Development, Evaluation, and Application of an In Silico Model for Antimalarial Drug Treatment and Failure

Author(s): 
Katherine Winter and Ian M. Hastings
Reference: 
Antimicrobial Agents and Chemotherapy, July 2011,p. 3380-3392, Vol. 55, No. 7
Contact email: 
hastings@liverpool.ac.uk

Pharmacological mechanism-based modeling was refined and used to develop an in silico model of antimalarial drug treatment validated against clinical and field data.

Syndicate content